Three-dimensional Ultrasonography Thyroid Volume Measurement.

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Recruiting
CT.gov ID
NCT05510609
Collaborator
(none)
17
1
1
5.8
2.9

Study Details

Study Description

Brief Summary

The purpose of this clinical trial is to investigate the accuracy of applying three-dimensional ultrasound on thyroid gland patients when determining a gland volume.

The method will be compared to conventional b-mode ultrasound where three axis measurements (length, width, and depth) are evaluated in the ellipsoid model.

The three dimensional (3D) method is utilizing optical tracking connected to the ultrasound image to form cross-sectional imaging. Patients enrolled in the study are set for complete thyroidectomies enabling a true volume of the gland by water displacement after excision.

The aim is to find if this 3D method is more accurate in volume estimation than the ellipsoid model.

Condition or Disease Intervention/Treatment Phase
  • Device: BK 5000 Ultrasound Machine
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
17 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Three-dimensional Ultrasonography: Accuracy in Thyroid Volume Measurement.
Actual Study Start Date :
May 9, 2022
Anticipated Primary Completion Date :
Oct 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Thyroidectomy

Patients set for total thyroidectomy incl. functional total thyroidectomies.

Device: BK 5000 Ultrasound Machine
Both 2D and 3D ultrasound is being used. 3D using optical tracking.

Outcome Measures

Primary Outcome Measures

  1. Thyroid volume [1 hour]

    Obtaining thyroid volume with 2D ultrasound (length x Width x depth*(Pi/6)) and 3D ultrasound with optical tracking and comparing the respective methods with a reference volume. Water displacement being gold standard for reference volume.

Secondary Outcome Measures

  1. Shrinkage in gland after excision [30 minutes]

    Looking af the change in volume invivo vs exvivo w. 2D and 3D ultrasound

  2. Interobserver variability [2 hours]

    Variation in volume estimation when delineating ultrasound images.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients referred to Rigshospitalet to undergo a complete thyroidectomy including patients with previous hemithyroidectomy

  • Adults, 18 or older.

  • Ability to give written informed consent

Exclusion Criteria:
  • Thyroid glands that are too enlarged causing visualization/measurement impairment with ultrasonography.

  • Thyroid cancer with preoperative suspected extracapsular spread.

  • Thyroids or lymph nodes that need frozen section examination.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rigshospitalet Copenhagen Capital Denmark 2100

Sponsors and Collaborators

  • Rigshospitalet, Denmark

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Klara Bay Rask, Stud.Med., Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT05510609
Other Study ID Numbers:
  • H-22011900
First Posted:
Aug 22, 2022
Last Update Posted:
Aug 22, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Klara Bay Rask, Stud.Med., Rigshospitalet, Denmark
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2022